Cargando…
Tumor suppressor PTEN affects tau phosphorylation: deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau
BACKGROUND: Aberrant hyperphosphorylation of tau protein has been implicated in a variety of neurodegenerative disorders. Although a number of protein kinases have been shown to phosphorylate tau in vitro and in vivo, the molecular mechanisms by which tau phosphorylation is regulated pathophysiologi...
Autores principales: | Zhang, Xue, Zhang, Yun-wu, Liu, Shijie, Bulloj, Ayelen, Tong, Gary G, Zhang, Zhuohua, Liao, Francesca-Fang, Xu, Huaxi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559623/ https://www.ncbi.nlm.nih.gov/pubmed/16930454 http://dx.doi.org/10.1186/1750-1326-1-7 |
Ejemplares similares
-
Quantitative and combinatory determination of in situ phosphorylation of tau and its FTDP-17 mutants
por: Kimura, Taeko, et al.
Publicado: (2016) -
The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells
por: Di Primio, Cristina, et al.
Publicado: (2017) -
Behavioral and Neuropathological Phenotyping of the Tau58/2 and Tau58/4 Transgenic Mouse Models for FTDP-17
por: Van Dam, Debby, et al.
Publicado: (2023) -
Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing
por: Rodriguez-Martin, Teresa, et al.
Publicado: (2009) -
PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer
por: Sun, Yizhe, et al.
Publicado: (2021)